“Importantly, Ii-key has been tested safely and successfully in many animal experiments, and in human clinical trials, and a SARS-CoV-2 vaccine design using Ii-key is currently being tested by a U.S.-China consortium125.”
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links